Current status: 1123 hESC lines, 7670 hiPSC lines, and 205 clinical studies, and 2402 certificates
Monthly statistic from Feb 1, 2026
Posted on February 1, 2026
| total lines | 8793 |
| hESC lines | 1123 |
| hiPSC lines | 7670 |
| derivation countries | 52 |
| projects | 335 |
| providers | 1035 |
| clinical studies | 205 |
| subclones | 3947 |
| certificates | 2402 |
| cell line certificates | 2247 |
| project certificates | 155 |